{
  "success": true,
  "pagesUsed": [
    17,
    18,
    19,
    20,
    45,
    46,
    47,
    48,
    49
  ],
  "modelUsed": "gemini-3-flash-preview",
  "eligibility": {
    "eligibilityCriterionItems": [
      {
        "id": "eci_1",
        "name": "Informed Consent",
        "text": "Signed Informed Consent Form",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_2",
        "name": "Age Requirement",
        "text": "Age 18 years at time of signing Informed Consent Form",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_3",
        "name": "Protocol Compliance",
        "text": "Ability to comply with the study protocol",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_4",
        "name": "Contraception Requirements",
        "text": "For women of childbearing potential: agreement to remain abstinent (refrain from heterosexual intercourse) or use contraception, and agreement to refrain from donating eggs, as defined below: Women must remain abstinent or use contraceptive methods with a failure rate of 1% per year during the treatment period and for 3 months after the final dose of study treatment. Women must refrain from donating eggs during this same period.",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_5",
        "name": "China Enrollment Phase",
        "text": "For patients enrolled in the extended China enrollment phase at NMPA-recognized sites: current resident of mainland China, Hong Kong, or Taiwan, and of Chinese ancestry",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_6",
        "name": "BRVO Diagnosis",
        "text": "Foveal center–involved macular edema due to BRVO diagnosed no longer than 4 months prior to the screening visit and confirmed by central reading center (CRC) based on SD-OCT (or SS-OCT) images. BRVO is defined by retinal hemorrhages, telangiectatic capillary bed, dilated venous system or other biomicroscopic evidence of retinal vein occlusion (RVO; neovascularization, vitreous hemorrhages) in one quadrant or less of the retina drained by the affected vein",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_7",
        "name": "BCVA Range",
        "text": "BCVA of 73 to 19 letters, inclusive (20/40 to 20/400 approximate Snellen equivalent), as assessed on the ETDRS visual acuity chart at a starting test distance of 4 meters (see the BCVA manual for additional details) on Day 1",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_8",
        "name": "CST Measurement",
        "text": "CST 325 m, as measured on Spectralis SD-OCT, or 315 m, as measured on Cirrus SD-OCT or Topcon SD-OCT at screening (SS-OCT acceptable after confirmation with CRC)",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_9",
        "name": "Ocular Media Clarity",
        "text": "Sufficiently clear ocular media and adequate pupillary dilatation to allow acquisition of good quality retinal images to confirm diagnosis",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_10",
        "name": "Major Illness or Surgery",
        "text": "Any major illness or major surgical procedure within 1 month before screening",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_11",
        "name": "Active Cancer",
        "text": "Active cancer within the 12 months prior to Day 1 except for appropriately treated carcinoma in situ of the cervix, non-melanoma skin carcinoma, and prostate cancer with a Gleason score of 6 and a stable prostate-specific antigen for 12 months",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_12",
        "name": "Prohibited Therapy",
        "text": "Requirement for continuous use of any medications and treatments indicated in Section 4.4.2 (Prohibited Therapy)",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_13",
        "name": "Systemic Infection",
        "text": "Systemic treatment for suspected or active systemic infection on Day 1. Ongoing use of prophylactic antibiotic therapy may be acceptable if approved after discussion with the Medical Monitor.",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_14",
        "name": "Systemic Corticosteroid Use",
        "text": "Any systemic corticosteroid use (e.g., oral or injectable) within 1 month of the screening visit",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_15",
        "name": "Uncontrolled Blood Pressure",
        "text": "Uncontrolled blood pressure, defined as systolic blood pressure 180 mmHg and/or diastolic blood pressure 110 mmHg while a patient is at rest on Day 1",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_16",
        "name": "Stroke or Myocardial Infarction",
        "text": "Stroke (cerebral vascular accident) or myocardial infarction within 6 months prior to Day 1",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_17",
        "name": "Other Disease or Condition",
        "text": "History of other disease, metabolic dysfunction, physical examination finding, or historical or current clinical laboratory findings giving reasonable suspicion of a condition that contraindicates the use of the investigational drug or that might affect interpretation of the results of the study or renders the patient at high risk for treatment complications in the opinion of the investigator",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_18",
        "name": "Pregnancy or Breastfeeding",
        "text": "Pregnant or breastfeeding, or intending to become pregnant during the study",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_19",
        "name": "Severe Allergic Reaction",
        "text": "History of a severe allergic reaction or anaphylactic reaction to a biologic agent or known hypersensitivity to any component of the faricimab or aflibercept injections, study- related procedure preparations (including fluorescein), dilating drops, or any of the anesthetic and antimicrobial preparations used during the study",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_20",
        "name": "Investigational Trial Participation",
        "text": "Participation in an investigational trial that involves treatment with any drug or device (with the exception of vitamins and minerals) within 3 months prior to Day 1",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_21",
        "name": "Previous RVO Episodes",
        "text": "History of previous episodes of macular edema due to RVO or persistent macular edema due to RVO diagnosed more than 4 months before screening",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_22",
        "name": "BCVA Increase",
        "text": "Increase of 10 letters in BCVA ETDRS score between screening and Day 1",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_23",
        "name": "Irreversible Vision Loss Cause",
        "text": "Any current ocular condition which, in the opinion of the investigator, is currently causing or could be expected to contribute to irreversible vision loss due to a cause other than macular edema due to RVO in the study eye (e.g., ischemic maculopathy, Irvine-Gass syndrome, foveal atrophy, foveal fibrosis, pigment abnormalities, dense subfoveal hard exudates, or other non-retinal conditions)",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_24",
        "name": "Vitreous Hemorrhage",
        "text": "Current visually significant vitreous hemorrhage on Day 1",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_25",
        "name": "Retinal Detachment or Macular Hole",
        "text": "History of retinal detachment or macular hole (Stage 3 or 4)",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_26",
        "name": "Macular Architecture Disruption",
        "text": "Tractional retinal detachment, vitreomacular traction, full thickness macular hole or epiretinal membrane involving the fovea or disrupting the macular architecture in the study eye, as evaluated by the CRC and described in the CRC manual",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_27",
        "name": "Other Retinal Diagnosis",
        "text": "Diagnosis of diabetic retinopathy (DR) moderate non-proliferative or worse, proliferative DR, diabetic macular edema (DME), neovascular age-related macular degeneration (nAMD), geographic atrophy, myopic choroidal neovascularization as assessed by the investigator",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_28",
        "name": "Neovascular Conditions",
        "text": "Active rubeosis, angle neovascularization, neovascular glaucoma",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_29",
        "name": "Aphakia or Anterior Lens",
        "text": "Aphakia or implantation of anterior chamber intraocular lens",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_30",
        "name": "Recent Cataract Surgery",
        "text": "Any cataract surgery or treatment for complications of cataract surgery with steroids or YAG (yttrium-aluminum-garnet) laser capsulotomy within 3 months prior to Day 1",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_31",
        "name": "Other Intraocular Surgery",
        "text": "Any other intraocular surgery (e.g., pars plana vitrectomy, scleral buckle, glaucoma surgery, corneal transplant, or radiotherapy)",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_32",
        "name": "Prior RVO Treatment",
        "text": "Any prior or current treatment for macular edema due to RVO, including antivascular endothelial growth factor (VEGF) IVT for macular edema due to RVO",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_33",
        "name": "Macular Laser",
        "text": "Macular laser (focal/grid) in the study eye at any time prior to Day 1",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_34",
        "name": "Panretinal Photocoagulation",
        "text": "Panretinal photocoagulation in the study eye within 3 months prior to Day 1 or anticipated within 3 months of study start on Day 1",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_35",
        "name": "Other IVT Treatment",
        "text": "Any IVT treatment for any other retinal diseases that can lead to macular edema complication",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_36",
        "name": "Prior Macular Edema Treatment",
        "text": "Any prior or current treatment for macular edema; macular neovascularization, including DME and nAMD; and vitreomacular-interface abnormalities, including, but not restricted to, IVT treatment with anti-VEGF, steroids, tissue plasminogen activator, ocriplasmin, C3F8, air or periocular injection",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_37",
        "name": "Prior Laser or Surgery Interventions",
        "text": "Any prior intervention with verteporfin photodynamic therapy, diode laser, transpupillary thermotherapy, or vitreo-retinal surgery including sheathotomy",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_38",
        "name": "Prior Steroid Implant",
        "text": "Any prior steroid implant use including dexamethasone intravitreal implant (Ozurdex) and fluocinolone acetonide intravitreal implant (Iluvien)",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_39",
        "name": "Prior Periocular Treatment",
        "text": "Prior periocular pharmacological or IVT treatment (including anti-VEGF medication) for other retinal diseases",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_40",
        "name": "Non-functioning Fellow Eye",
        "text": "Non-functioning fellow eye, defined as either one of the following: BCVA 20/320 or worse; No physical presence of fellow eye (i.e., monocular)",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_41",
        "name": "Prior Faricimab Use",
        "text": "Prior IVT administration of faricimab in either eye",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_42",
        "name": "History of Uveitis",
        "text": "History of idiopathic or autoimmune-associated uveitis in either eye",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_43",
        "name": "Active Ocular Inflammation",
        "text": "Active periocular, ocular or intraocular inflammation or infection (including suspected) in either eye on Day 1",
        "instanceType": "EligibilityCriterionItem"
      }
    ],
    "eligibilityCriteria": [
      {
        "id": "ec_1",
        "identifier": "I1",
        "category": {
          "code": "Inclusion",
          "codeSystem": "USDM",
          "decode": "Inclusion"
        },
        "criterionItemId": "eci_1",
        "instanceType": "EligibilityCriterion",
        "name": "Informed Consent",
        "nextId": "ec_2"
      },
      {
        "id": "ec_2",
        "identifier": "I2",
        "category": {
          "code": "Inclusion",
          "codeSystem": "USDM",
          "decode": "Inclusion"
        },
        "criterionItemId": "eci_2",
        "instanceType": "EligibilityCriterion",
        "name": "Age Requirement",
        "previousId": "ec_1",
        "nextId": "ec_3"
      },
      {
        "id": "ec_3",
        "identifier": "I3",
        "category": {
          "code": "Inclusion",
          "codeSystem": "USDM",
          "decode": "Inclusion"
        },
        "criterionItemId": "eci_3",
        "instanceType": "EligibilityCriterion",
        "name": "Protocol Compliance",
        "previousId": "ec_2",
        "nextId": "ec_4"
      },
      {
        "id": "ec_4",
        "identifier": "I4",
        "category": {
          "code": "Inclusion",
          "codeSystem": "USDM",
          "decode": "Inclusion"
        },
        "criterionItemId": "eci_4",
        "instanceType": "EligibilityCriterion",
        "name": "Contraception Requirements",
        "previousId": "ec_3",
        "nextId": "ec_5"
      },
      {
        "id": "ec_5",
        "identifier": "I5",
        "category": {
          "code": "Inclusion",
          "codeSystem": "USDM",
          "decode": "Inclusion"
        },
        "criterionItemId": "eci_5",
        "instanceType": "EligibilityCriterion",
        "name": "China Enrollment Phase",
        "previousId": "ec_4",
        "nextId": "ec_6"
      },
      {
        "id": "ec_6",
        "identifier": "I6",
        "category": {
          "code": "Inclusion",
          "codeSystem": "USDM",
          "decode": "Inclusion"
        },
        "criterionItemId": "eci_6",
        "instanceType": "EligibilityCriterion",
        "name": "BRVO Diagnosis",
        "previousId": "ec_5",
        "nextId": "ec_7"
      },
      {
        "id": "ec_7",
        "identifier": "I7",
        "category": {
          "code": "Inclusion",
          "codeSystem": "USDM",
          "decode": "Inclusion"
        },
        "criterionItemId": "eci_7",
        "instanceType": "EligibilityCriterion",
        "name": "BCVA Range",
        "previousId": "ec_6",
        "nextId": "ec_8"
      },
      {
        "id": "ec_8",
        "identifier": "I8",
        "category": {
          "code": "Inclusion",
          "codeSystem": "USDM",
          "decode": "Inclusion"
        },
        "criterionItemId": "eci_8",
        "instanceType": "EligibilityCriterion",
        "name": "CST Measurement",
        "previousId": "ec_7",
        "nextId": "ec_9"
      },
      {
        "id": "ec_9",
        "identifier": "I9",
        "category": {
          "code": "Inclusion",
          "codeSystem": "USDM",
          "decode": "Inclusion"
        },
        "criterionItemId": "eci_9",
        "instanceType": "EligibilityCriterion",
        "name": "Ocular Media Clarity",
        "previousId": "ec_8"
      },
      {
        "id": "ec_10",
        "identifier": "E1",
        "category": {
          "code": "Exclusion",
          "codeSystem": "USDM",
          "decode": "Exclusion"
        },
        "criterionItemId": "eci_10",
        "instanceType": "EligibilityCriterion",
        "name": "Major Illness or Surgery",
        "nextId": "ec_11"
      },
      {
        "id": "ec_11",
        "identifier": "E2",
        "category": {
          "code": "Exclusion",
          "codeSystem": "USDM",
          "decode": "Exclusion"
        },
        "criterionItemId": "eci_11",
        "instanceType": "EligibilityCriterion",
        "name": "Active Cancer",
        "previousId": "ec_10",
        "nextId": "ec_12"
      },
      {
        "id": "ec_12",
        "identifier": "E3",
        "category": {
          "code": "Exclusion",
          "codeSystem": "USDM",
          "decode": "Exclusion"
        },
        "criterionItemId": "eci_12",
        "instanceType": "EligibilityCriterion",
        "name": "Prohibited Therapy",
        "previousId": "ec_11",
        "nextId": "ec_13"
      },
      {
        "id": "ec_13",
        "identifier": "E4",
        "category": {
          "code": "Exclusion",
          "codeSystem": "USDM",
          "decode": "Exclusion"
        },
        "criterionItemId": "eci_13",
        "instanceType": "EligibilityCriterion",
        "name": "Systemic Infection",
        "previousId": "ec_12",
        "nextId": "ec_14"
      },
      {
        "id": "ec_14",
        "identifier": "E5",
        "category": {
          "code": "Exclusion",
          "codeSystem": "USDM",
          "decode": "Exclusion"
        },
        "criterionItemId": "eci_14",
        "instanceType": "EligibilityCriterion",
        "name": "Systemic Corticosteroid Use",
        "previousId": "ec_13",
        "nextId": "ec_15"
      },
      {
        "id": "ec_15",
        "identifier": "E6",
        "category": {
          "code": "Exclusion",
          "codeSystem": "USDM",
          "decode": "Exclusion"
        },
        "criterionItemId": "eci_15",
        "instanceType": "EligibilityCriterion",
        "name": "Uncontrolled Blood Pressure",
        "previousId": "ec_14",
        "nextId": "ec_16"
      },
      {
        "id": "ec_16",
        "identifier": "E7",
        "category": {
          "code": "Exclusion",
          "codeSystem": "USDM",
          "decode": "Exclusion"
        },
        "criterionItemId": "eci_16",
        "instanceType": "EligibilityCriterion",
        "name": "Stroke or Myocardial Infarction",
        "previousId": "ec_15",
        "nextId": "ec_17"
      },
      {
        "id": "ec_17",
        "identifier": "E8",
        "category": {
          "code": "Exclusion",
          "codeSystem": "USDM",
          "decode": "Exclusion"
        },
        "criterionItemId": "eci_17",
        "instanceType": "EligibilityCriterion",
        "name": "Other Disease or Condition",
        "previousId": "ec_16",
        "nextId": "ec_18"
      },
      {
        "id": "ec_18",
        "identifier": "E9",
        "category": {
          "code": "Exclusion",
          "codeSystem": "USDM",
          "decode": "Exclusion"
        },
        "criterionItemId": "eci_18",
        "instanceType": "EligibilityCriterion",
        "name": "Pregnancy or Breastfeeding",
        "previousId": "ec_17",
        "nextId": "ec_19"
      },
      {
        "id": "ec_19",
        "identifier": "E10",
        "category": {
          "code": "Exclusion",
          "codeSystem": "USDM",
          "decode": "Exclusion"
        },
        "criterionItemId": "eci_19",
        "instanceType": "EligibilityCriterion",
        "name": "Severe Allergic Reaction",
        "previousId": "ec_18",
        "nextId": "ec_20"
      },
      {
        "id": "ec_20",
        "identifier": "E11",
        "category": {
          "code": "Exclusion",
          "codeSystem": "USDM",
          "decode": "Exclusion"
        },
        "criterionItemId": "eci_20",
        "instanceType": "EligibilityCriterion",
        "name": "Investigational Trial Participation",
        "previousId": "ec_19",
        "nextId": "ec_21"
      },
      {
        "id": "ec_21",
        "identifier": "E12",
        "category": {
          "code": "Exclusion",
          "codeSystem": "USDM",
          "decode": "Exclusion"
        },
        "criterionItemId": "eci_21",
        "instanceType": "EligibilityCriterion",
        "name": "Previous RVO Episodes",
        "previousId": "ec_20",
        "nextId": "ec_22"
      },
      {
        "id": "ec_22",
        "identifier": "E13",
        "category": {
          "code": "Exclusion",
          "codeSystem": "USDM",
          "decode": "Exclusion"
        },
        "criterionItemId": "eci_22",
        "instanceType": "EligibilityCriterion",
        "name": "BCVA Increase",
        "previousId": "ec_21",
        "nextId": "ec_23"
      },
      {
        "id": "ec_23",
        "identifier": "E14",
        "category": {
          "code": "Exclusion",
          "codeSystem": "USDM",
          "decode": "Exclusion"
        },
        "criterionItemId": "eci_23",
        "instanceType": "EligibilityCriterion",
        "name": "Irreversible Vision Loss Cause",
        "previousId": "ec_22",
        "nextId": "ec_24"
      },
      {
        "id": "ec_24",
        "identifier": "E15",
        "category": {
          "code": "Exclusion",
          "codeSystem": "USDM",
          "decode": "Exclusion"
        },
        "criterionItemId": "eci_24",
        "instanceType": "EligibilityCriterion",
        "name": "Vitreous Hemorrhage",
        "previousId": "ec_23",
        "nextId": "ec_25"
      },
      {
        "id": "ec_25",
        "identifier": "E16",
        "category": {
          "code": "Exclusion",
          "codeSystem": "USDM",
          "decode": "Exclusion"
        },
        "criterionItemId": "eci_25",
        "instanceType": "EligibilityCriterion",
        "name": "Retinal Detachment or Macular Hole",
        "previousId": "ec_24",
        "nextId": "ec_26"
      },
      {
        "id": "ec_26",
        "identifier": "E17",
        "category": {
          "code": "Exclusion",
          "codeSystem": "USDM",
          "decode": "Exclusion"
        },
        "criterionItemId": "eci_26",
        "instanceType": "EligibilityCriterion",
        "name": "Macular Architecture Disruption",
        "previousId": "ec_25",
        "nextId": "ec_27"
      },
      {
        "id": "ec_27",
        "identifier": "E18",
        "category": {
          "code": "Exclusion",
          "codeSystem": "USDM",
          "decode": "Exclusion"
        },
        "criterionItemId": "eci_27",
        "instanceType": "EligibilityCriterion",
        "name": "Other Retinal Diagnosis",
        "previousId": "ec_26",
        "nextId": "ec_28"
      },
      {
        "id": "ec_28",
        "identifier": "E19",
        "category": {
          "code": "Exclusion",
          "codeSystem": "USDM",
          "decode": "Exclusion"
        },
        "criterionItemId": "eci_28",
        "instanceType": "EligibilityCriterion",
        "name": "Neovascular Conditions",
        "previousId": "ec_27",
        "nextId": "ec_29"
      },
      {
        "id": "ec_29",
        "identifier": "E20",
        "category": {
          "code": "Exclusion",
          "codeSystem": "USDM",
          "decode": "Exclusion"
        },
        "criterionItemId": "eci_29",
        "instanceType": "EligibilityCriterion",
        "name": "Aphakia or Anterior Lens",
        "previousId": "ec_28",
        "nextId": "ec_30"
      },
      {
        "id": "ec_30",
        "identifier": "E21",
        "category": {
          "code": "Exclusion",
          "codeSystem": "USDM",
          "decode": "Exclusion"
        },
        "criterionItemId": "eci_30",
        "instanceType": "EligibilityCriterion",
        "name": "Recent Cataract Surgery",
        "previousId": "ec_29",
        "nextId": "ec_31"
      },
      {
        "id": "ec_31",
        "identifier": "E22",
        "category": {
          "code": "Exclusion",
          "codeSystem": "USDM",
          "decode": "Exclusion"
        },
        "criterionItemId": "eci_31",
        "instanceType": "EligibilityCriterion",
        "name": "Other Intraocular Surgery",
        "previousId": "ec_30",
        "nextId": "ec_32"
      },
      {
        "id": "ec_32",
        "identifier": "E23",
        "category": {
          "code": "Exclusion",
          "codeSystem": "USDM",
          "decode": "Exclusion"
        },
        "criterionItemId": "eci_32",
        "instanceType": "EligibilityCriterion",
        "name": "Prior RVO Treatment",
        "previousId": "ec_31",
        "nextId": "ec_33"
      },
      {
        "id": "ec_33",
        "identifier": "E24",
        "category": {
          "code": "Exclusion",
          "codeSystem": "USDM",
          "decode": "Exclusion"
        },
        "criterionItemId": "eci_33",
        "instanceType": "EligibilityCriterion",
        "name": "Macular Laser",
        "previousId": "ec_32",
        "nextId": "ec_34"
      },
      {
        "id": "ec_34",
        "identifier": "E25",
        "category": {
          "code": "Exclusion",
          "codeSystem": "USDM",
          "decode": "Exclusion"
        },
        "criterionItemId": "eci_34",
        "instanceType": "EligibilityCriterion",
        "name": "Panretinal Photocoagulation",
        "previousId": "ec_33",
        "nextId": "ec_35"
      },
      {
        "id": "ec_35",
        "identifier": "E26",
        "category": {
          "code": "Exclusion",
          "codeSystem": "USDM",
          "decode": "Exclusion"
        },
        "criterionItemId": "eci_35",
        "instanceType": "EligibilityCriterion",
        "name": "Other IVT Treatment",
        "previousId": "ec_34",
        "nextId": "ec_36"
      },
      {
        "id": "ec_36",
        "identifier": "E27",
        "category": {
          "code": "Exclusion",
          "codeSystem": "USDM",
          "decode": "Exclusion"
        },
        "criterionItemId": "eci_36",
        "instanceType": "EligibilityCriterion",
        "name": "Prior Macular Edema Treatment",
        "previousId": "ec_35",
        "nextId": "ec_37"
      },
      {
        "id": "ec_37",
        "identifier": "E28",
        "category": {
          "code": "Exclusion",
          "codeSystem": "USDM",
          "decode": "Exclusion"
        },
        "criterionItemId": "eci_37",
        "instanceType": "EligibilityCriterion",
        "name": "Prior Laser or Surgery Interventions",
        "previousId": "ec_36",
        "nextId": "ec_38"
      },
      {
        "id": "ec_38",
        "identifier": "E29",
        "category": {
          "code": "Exclusion",
          "codeSystem": "USDM",
          "decode": "Exclusion"
        },
        "criterionItemId": "eci_38",
        "instanceType": "EligibilityCriterion",
        "name": "Prior Steroid Implant",
        "previousId": "ec_37",
        "nextId": "ec_39"
      },
      {
        "id": "ec_39",
        "identifier": "E30",
        "category": {
          "code": "Exclusion",
          "codeSystem": "USDM",
          "decode": "Exclusion"
        },
        "criterionItemId": "eci_39",
        "instanceType": "EligibilityCriterion",
        "name": "Prior Periocular Treatment",
        "previousId": "ec_38",
        "nextId": "ec_40"
      },
      {
        "id": "ec_40",
        "identifier": "E31",
        "category": {
          "code": "Exclusion",
          "codeSystem": "USDM",
          "decode": "Exclusion"
        },
        "criterionItemId": "eci_40",
        "instanceType": "EligibilityCriterion",
        "name": "Non-functioning Fellow Eye",
        "previousId": "ec_39",
        "nextId": "ec_41"
      },
      {
        "id": "ec_41",
        "identifier": "E32",
        "category": {
          "code": "Exclusion",
          "codeSystem": "USDM",
          "decode": "Exclusion"
        },
        "criterionItemId": "eci_41",
        "instanceType": "EligibilityCriterion",
        "name": "Prior Faricimab Use",
        "previousId": "ec_40",
        "nextId": "ec_42"
      },
      {
        "id": "ec_42",
        "identifier": "E33",
        "category": {
          "code": "Exclusion",
          "codeSystem": "USDM",
          "decode": "Exclusion"
        },
        "criterionItemId": "eci_42",
        "instanceType": "EligibilityCriterion",
        "name": "History of Uveitis",
        "previousId": "ec_41",
        "nextId": "ec_43"
      },
      {
        "id": "ec_43",
        "identifier": "E34",
        "category": {
          "code": "Exclusion",
          "codeSystem": "USDM",
          "decode": "Exclusion"
        },
        "criterionItemId": "eci_43",
        "instanceType": "EligibilityCriterion",
        "name": "Active Ocular Inflammation",
        "previousId": "ec_42"
      }
    ],
    "summary": {
      "inclusionCount": 9,
      "exclusionCount": 34,
      "totalCount": 43
    },
    "population": {
      "id": "pop_1",
      "name": "Study Population",
      "includesHealthySubjects": false,
      "criterionIds": [
        "ec_1",
        "ec_2",
        "ec_3",
        "ec_4",
        "ec_5",
        "ec_6",
        "ec_7",
        "ec_8",
        "ec_9",
        "ec_10",
        "ec_11",
        "ec_12",
        "ec_13",
        "ec_14",
        "ec_15",
        "ec_16",
        "ec_17",
        "ec_18",
        "ec_19",
        "ec_20",
        "ec_21",
        "ec_22",
        "ec_23",
        "ec_24",
        "ec_25",
        "ec_26",
        "ec_27",
        "ec_28",
        "ec_29",
        "ec_30",
        "ec_31",
        "ec_32",
        "ec_33",
        "ec_34",
        "ec_35",
        "ec_36",
        "ec_37",
        "ec_38",
        "ec_39",
        "ec_40",
        "ec_41",
        "ec_42",
        "ec_43"
      ],
      "instanceType": "StudyDesignPopulation",
      "description": "Target population defined by eligibility criteria"
    }
  },
  "rawResponse": {
    "eligibilityCriteria": [
      {
        "id": "ec_1",
        "name": "Informed Consent",
        "identifier": "I1",
        "category": {
          "code": "Inclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Inclusion Criterion"
        },
        "criterionItemId": "eci_1",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_2",
        "name": "Age Requirement",
        "identifier": "I2",
        "category": {
          "code": "Inclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Inclusion Criterion"
        },
        "criterionItemId": "eci_2",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_3",
        "name": "Protocol Compliance",
        "identifier": "I3",
        "category": {
          "code": "Inclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Inclusion Criterion"
        },
        "criterionItemId": "eci_3",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_4",
        "name": "Contraception Requirements",
        "identifier": "I4",
        "category": {
          "code": "Inclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Inclusion Criterion"
        },
        "criterionItemId": "eci_4",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_5",
        "name": "China Enrollment Phase",
        "identifier": "I5",
        "category": {
          "code": "Inclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Inclusion Criterion"
        },
        "criterionItemId": "eci_5",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_6",
        "name": "BRVO Diagnosis",
        "identifier": "I6",
        "category": {
          "code": "Inclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Inclusion Criterion"
        },
        "criterionItemId": "eci_6",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_7",
        "name": "BCVA Range",
        "identifier": "I7",
        "category": {
          "code": "Inclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Inclusion Criterion"
        },
        "criterionItemId": "eci_7",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_8",
        "name": "CST Measurement",
        "identifier": "I8",
        "category": {
          "code": "Inclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Inclusion Criterion"
        },
        "criterionItemId": "eci_8",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_9",
        "name": "Ocular Media Clarity",
        "identifier": "I9",
        "category": {
          "code": "Inclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Inclusion Criterion"
        },
        "criterionItemId": "eci_9",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_10",
        "name": "Major Illness or Surgery",
        "identifier": "E1",
        "category": {
          "code": "Exclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Exclusion Criterion"
        },
        "criterionItemId": "eci_10",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_11",
        "name": "Active Cancer",
        "identifier": "E2",
        "category": {
          "code": "Exclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Exclusion Criterion"
        },
        "criterionItemId": "eci_11",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_12",
        "name": "Prohibited Therapy",
        "identifier": "E3",
        "category": {
          "code": "Exclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Exclusion Criterion"
        },
        "criterionItemId": "eci_12",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_13",
        "name": "Systemic Infection",
        "identifier": "E4",
        "category": {
          "code": "Exclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Exclusion Criterion"
        },
        "criterionItemId": "eci_13",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_14",
        "name": "Systemic Corticosteroid Use",
        "identifier": "E5",
        "category": {
          "code": "Exclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Exclusion Criterion"
        },
        "criterionItemId": "eci_14",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_15",
        "name": "Uncontrolled Blood Pressure",
        "identifier": "E6",
        "category": {
          "code": "Exclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Exclusion Criterion"
        },
        "criterionItemId": "eci_15",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_16",
        "name": "Stroke or Myocardial Infarction",
        "identifier": "E7",
        "category": {
          "code": "Exclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Exclusion Criterion"
        },
        "criterionItemId": "eci_16",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_17",
        "name": "Other Disease or Condition",
        "identifier": "E8",
        "category": {
          "code": "Exclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Exclusion Criterion"
        },
        "criterionItemId": "eci_17",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_18",
        "name": "Pregnancy or Breastfeeding",
        "identifier": "E9",
        "category": {
          "code": "Exclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Exclusion Criterion"
        },
        "criterionItemId": "eci_18",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_19",
        "name": "Severe Allergic Reaction",
        "identifier": "E10",
        "category": {
          "code": "Exclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Exclusion Criterion"
        },
        "criterionItemId": "eci_19",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_20",
        "name": "Investigational Trial Participation",
        "identifier": "E11",
        "category": {
          "code": "Exclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Exclusion Criterion"
        },
        "criterionItemId": "eci_20",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_21",
        "name": "Previous RVO Episodes",
        "identifier": "E12",
        "category": {
          "code": "Exclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Exclusion Criterion"
        },
        "criterionItemId": "eci_21",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_22",
        "name": "BCVA Increase",
        "identifier": "E13",
        "category": {
          "code": "Exclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Exclusion Criterion"
        },
        "criterionItemId": "eci_22",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_23",
        "name": "Irreversible Vision Loss Cause",
        "identifier": "E14",
        "category": {
          "code": "Exclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Exclusion Criterion"
        },
        "criterionItemId": "eci_23",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_24",
        "name": "Vitreous Hemorrhage",
        "identifier": "E15",
        "category": {
          "code": "Exclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Exclusion Criterion"
        },
        "criterionItemId": "eci_24",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_25",
        "name": "Retinal Detachment or Macular Hole",
        "identifier": "E16",
        "category": {
          "code": "Exclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Exclusion Criterion"
        },
        "criterionItemId": "eci_25",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_26",
        "name": "Macular Architecture Disruption",
        "identifier": "E17",
        "category": {
          "code": "Exclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Exclusion Criterion"
        },
        "criterionItemId": "eci_26",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_27",
        "name": "Other Retinal Diagnosis",
        "identifier": "E18",
        "category": {
          "code": "Exclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Exclusion Criterion"
        },
        "criterionItemId": "eci_27",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_28",
        "name": "Neovascular Conditions",
        "identifier": "E19",
        "category": {
          "code": "Exclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Exclusion Criterion"
        },
        "criterionItemId": "eci_28",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_29",
        "name": "Aphakia or Anterior Lens",
        "identifier": "E20",
        "category": {
          "code": "Exclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Exclusion Criterion"
        },
        "criterionItemId": "eci_29",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_30",
        "name": "Recent Cataract Surgery",
        "identifier": "E21",
        "category": {
          "code": "Exclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Exclusion Criterion"
        },
        "criterionItemId": "eci_30",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_31",
        "name": "Other Intraocular Surgery",
        "identifier": "E22",
        "category": {
          "code": "Exclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Exclusion Criterion"
        },
        "criterionItemId": "eci_31",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_32",
        "name": "Prior RVO Treatment",
        "identifier": "E23",
        "category": {
          "code": "Exclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Exclusion Criterion"
        },
        "criterionItemId": "eci_32",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_33",
        "name": "Macular Laser",
        "identifier": "E24",
        "category": {
          "code": "Exclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Exclusion Criterion"
        },
        "criterionItemId": "eci_33",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_34",
        "name": "Panretinal Photocoagulation",
        "identifier": "E25",
        "category": {
          "code": "Exclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Exclusion Criterion"
        },
        "criterionItemId": "eci_34",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_35",
        "name": "Other IVT Treatment",
        "identifier": "E26",
        "category": {
          "code": "Exclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Exclusion Criterion"
        },
        "criterionItemId": "eci_35",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_36",
        "name": "Prior Macular Edema Treatment",
        "identifier": "E27",
        "category": {
          "code": "Exclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Exclusion Criterion"
        },
        "criterionItemId": "eci_36",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_37",
        "name": "Prior Laser or Surgery Interventions",
        "identifier": "E28",
        "category": {
          "code": "Exclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Exclusion Criterion"
        },
        "criterionItemId": "eci_37",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_38",
        "name": "Prior Steroid Implant",
        "identifier": "E29",
        "category": {
          "code": "Exclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Exclusion Criterion"
        },
        "criterionItemId": "eci_38",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_39",
        "name": "Prior Periocular Treatment",
        "identifier": "E30",
        "category": {
          "code": "Exclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Exclusion Criterion"
        },
        "criterionItemId": "eci_39",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_40",
        "name": "Non-functioning Fellow Eye",
        "identifier": "E31",
        "category": {
          "code": "Exclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Exclusion Criterion"
        },
        "criterionItemId": "eci_40",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_41",
        "name": "Prior Faricimab Use",
        "identifier": "E32",
        "category": {
          "code": "Exclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Exclusion Criterion"
        },
        "criterionItemId": "eci_41",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_42",
        "name": "History of Uveitis",
        "identifier": "E33",
        "category": {
          "code": "Exclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Exclusion Criterion"
        },
        "criterionItemId": "eci_42",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_43",
        "name": "Active Ocular Inflammation",
        "identifier": "E34",
        "category": {
          "code": "Exclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Exclusion Criterion"
        },
        "criterionItemId": "eci_43",
        "instanceType": "EligibilityCriterion"
      }
    ],
    "eligibilityCriterionItems": [
      {
        "id": "eci_1",
        "name": "Informed Consent",
        "text": "Signed Informed Consent Form",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_2",
        "name": "Age Requirement",
        "text": "Age 18 years at time of signing Informed Consent Form",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_3",
        "name": "Protocol Compliance",
        "text": "Ability to comply with the study protocol",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_4",
        "name": "Contraception Requirements",
        "text": "For women of childbearing potential: agreement to remain abstinent (refrain from heterosexual intercourse) or use contraception, and agreement to refrain from donating eggs, as defined below: Women must remain abstinent or use contraceptive methods with a failure rate of 1% per year during the treatment period and for 3 months after the final dose of study treatment. Women must refrain from donating eggs during this same period.",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_5",
        "name": "China Enrollment Phase",
        "text": "For patients enrolled in the extended China enrollment phase at NMPA-recognized sites: current resident of mainland China, Hong Kong, or Taiwan, and of Chinese ancestry",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_6",
        "name": "BRVO Diagnosis",
        "text": "Foveal center–involved macular edema due to BRVO diagnosed no longer than 4 months prior to the screening visit and confirmed by central reading center (CRC) based on SD-OCT (or SS-OCT) images. BRVO is defined by retinal hemorrhages, telangiectatic capillary bed, dilated venous system or other biomicroscopic evidence of retinal vein occlusion (RVO; neovascularization, vitreous hemorrhages) in one quadrant or less of the retina drained by the affected vein",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_7",
        "name": "BCVA Range",
        "text": "BCVA of 73 to 19 letters, inclusive (20/40 to 20/400 approximate Snellen equivalent), as assessed on the ETDRS visual acuity chart at a starting test distance of 4 meters (see the BCVA manual for additional details) on Day 1",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_8",
        "name": "CST Measurement",
        "text": "CST 325 m, as measured on Spectralis SD-OCT, or 315 m, as measured on Cirrus SD-OCT or Topcon SD-OCT at screening (SS-OCT acceptable after confirmation with CRC)",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_9",
        "name": "Ocular Media Clarity",
        "text": "Sufficiently clear ocular media and adequate pupillary dilatation to allow acquisition of good quality retinal images to confirm diagnosis",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_10",
        "name": "Major Illness or Surgery",
        "text": "Any major illness or major surgical procedure within 1 month before screening",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_11",
        "name": "Active Cancer",
        "text": "Active cancer within the 12 months prior to Day 1 except for appropriately treated carcinoma in situ of the cervix, non-melanoma skin carcinoma, and prostate cancer with a Gleason score of 6 and a stable prostate-specific antigen for 12 months",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_12",
        "name": "Prohibited Therapy",
        "text": "Requirement for continuous use of any medications and treatments indicated in Section 4.4.2 (Prohibited Therapy)",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_13",
        "name": "Systemic Infection",
        "text": "Systemic treatment for suspected or active systemic infection on Day 1. Ongoing use of prophylactic antibiotic therapy may be acceptable if approved after discussion with the Medical Monitor.",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_14",
        "name": "Systemic Corticosteroid Use",
        "text": "Any systemic corticosteroid use (e.g., oral or injectable) within 1 month of the screening visit",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_15",
        "name": "Uncontrolled Blood Pressure",
        "text": "Uncontrolled blood pressure, defined as systolic blood pressure 180 mmHg and/or diastolic blood pressure 110 mmHg while a patient is at rest on Day 1",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_16",
        "name": "Stroke or Myocardial Infarction",
        "text": "Stroke (cerebral vascular accident) or myocardial infarction within 6 months prior to Day 1",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_17",
        "name": "Other Disease or Condition",
        "text": "History of other disease, metabolic dysfunction, physical examination finding, or historical or current clinical laboratory findings giving reasonable suspicion of a condition that contraindicates the use of the investigational drug or that might affect interpretation of the results of the study or renders the patient at high risk for treatment complications in the opinion of the investigator",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_18",
        "name": "Pregnancy or Breastfeeding",
        "text": "Pregnant or breastfeeding, or intending to become pregnant during the study",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_19",
        "name": "Severe Allergic Reaction",
        "text": "History of a severe allergic reaction or anaphylactic reaction to a biologic agent or known hypersensitivity to any component of the faricimab or aflibercept injections, study- related procedure preparations (including fluorescein), dilating drops, or any of the anesthetic and antimicrobial preparations used during the study",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_20",
        "name": "Investigational Trial Participation",
        "text": "Participation in an investigational trial that involves treatment with any drug or device (with the exception of vitamins and minerals) within 3 months prior to Day 1",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_21",
        "name": "Previous RVO Episodes",
        "text": "History of previous episodes of macular edema due to RVO or persistent macular edema due to RVO diagnosed more than 4 months before screening",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_22",
        "name": "BCVA Increase",
        "text": "Increase of 10 letters in BCVA ETDRS score between screening and Day 1",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_23",
        "name": "Irreversible Vision Loss Cause",
        "text": "Any current ocular condition which, in the opinion of the investigator, is currently causing or could be expected to contribute to irreversible vision loss due to a cause other than macular edema due to RVO in the study eye (e.g., ischemic maculopathy, Irvine-Gass syndrome, foveal atrophy, foveal fibrosis, pigment abnormalities, dense subfoveal hard exudates, or other non-retinal conditions)",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_24",
        "name": "Vitreous Hemorrhage",
        "text": "Current visually significant vitreous hemorrhage on Day 1",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_25",
        "name": "Retinal Detachment or Macular Hole",
        "text": "History of retinal detachment or macular hole (Stage 3 or 4)",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_26",
        "name": "Macular Architecture Disruption",
        "text": "Tractional retinal detachment, vitreomacular traction, full thickness macular hole or epiretinal membrane involving the fovea or disrupting the macular architecture in the study eye, as evaluated by the CRC and described in the CRC manual",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_27",
        "name": "Other Retinal Diagnosis",
        "text": "Diagnosis of diabetic retinopathy (DR) moderate non-proliferative or worse, proliferative DR, diabetic macular edema (DME), neovascular age-related macular degeneration (nAMD), geographic atrophy, myopic choroidal neovascularization as assessed by the investigator",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_28",
        "name": "Neovascular Conditions",
        "text": "Active rubeosis, angle neovascularization, neovascular glaucoma",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_29",
        "name": "Aphakia or Anterior Lens",
        "text": "Aphakia or implantation of anterior chamber intraocular lens",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_30",
        "name": "Recent Cataract Surgery",
        "text": "Any cataract surgery or treatment for complications of cataract surgery with steroids or YAG (yttrium-aluminum-garnet) laser capsulotomy within 3 months prior to Day 1",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_31",
        "name": "Other Intraocular Surgery",
        "text": "Any other intraocular surgery (e.g., pars plana vitrectomy, scleral buckle, glaucoma surgery, corneal transplant, or radiotherapy)",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_32",
        "name": "Prior RVO Treatment",
        "text": "Any prior or current treatment for macular edema due to RVO, including antivascular endothelial growth factor (VEGF) IVT for macular edema due to RVO",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_33",
        "name": "Macular Laser",
        "text": "Macular laser (focal/grid) in the study eye at any time prior to Day 1",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_34",
        "name": "Panretinal Photocoagulation",
        "text": "Panretinal photocoagulation in the study eye within 3 months prior to Day 1 or anticipated within 3 months of study start on Day 1",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_35",
        "name": "Other IVT Treatment",
        "text": "Any IVT treatment for any other retinal diseases that can lead to macular edema complication",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_36",
        "name": "Prior Macular Edema Treatment",
        "text": "Any prior or current treatment for macular edema; macular neovascularization, including DME and nAMD; and vitreomacular-interface abnormalities, including, but not restricted to, IVT treatment with anti-VEGF, steroids, tissue plasminogen activator, ocriplasmin, C3F8, air or periocular injection",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_37",
        "name": "Prior Laser or Surgery Interventions",
        "text": "Any prior intervention with verteporfin photodynamic therapy, diode laser, transpupillary thermotherapy, or vitreo-retinal surgery including sheathotomy",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_38",
        "name": "Prior Steroid Implant",
        "text": "Any prior steroid implant use including dexamethasone intravitreal implant (Ozurdex) and fluocinolone acetonide intravitreal implant (Iluvien)",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_39",
        "name": "Prior Periocular Treatment",
        "text": "Prior periocular pharmacological or IVT treatment (including anti-VEGF medication) for other retinal diseases",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_40",
        "name": "Non-functioning Fellow Eye",
        "text": "Non-functioning fellow eye, defined as either one of the following: BCVA 20/320 or worse; No physical presence of fellow eye (i.e., monocular)",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_41",
        "name": "Prior Faricimab Use",
        "text": "Prior IVT administration of faricimab in either eye",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_42",
        "name": "History of Uveitis",
        "text": "History of idiopathic or autoimmune-associated uveitis in either eye",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_43",
        "name": "Active Ocular Inflammation",
        "text": "Active periocular, ocular or intraocular inflammation or infection (including suspected) in either eye on Day 1",
        "instanceType": "EligibilityCriterionItem"
      }
    ],
    "population": {
      "id": "pop_1",
      "name": "Patients with macular edema due to BRVO",
      "includesHealthySubjects": false,
      "plannedEnrollmentNumber": {
        "maxValue": 570,
        "instanceType": "Range"
      },
      "plannedMinimumAge": "P18Y",
      "plannedSex": [
        {
          "code": "Male",
          "codeSystem": "http://www.cdisc.org/USDM/sex",
          "decode": "Male"
        },
        {
          "code": "Female",
          "codeSystem": "http://www.cdisc.org/USDM/sex",
          "decode": "Female"
        }
      ],
      "criterionIds": [
        "ec_1",
        "ec_2",
        "ec_3",
        "ec_4",
        "ec_5",
        "ec_6",
        "ec_7",
        "ec_8",
        "ec_9",
        "ec_10",
        "ec_11",
        "ec_12",
        "ec_13",
        "ec_14",
        "ec_15",
        "ec_16",
        "ec_17",
        "ec_18",
        "ec_19",
        "ec_20",
        "ec_21",
        "ec_22",
        "ec_23",
        "ec_24",
        "ec_25",
        "ec_26",
        "ec_27",
        "ec_28",
        "ec_29",
        "ec_30",
        "ec_31",
        "ec_32",
        "ec_33",
        "ec_34",
        "ec_35",
        "ec_36",
        "ec_37",
        "ec_38",
        "ec_39",
        "ec_40",
        "ec_41",
        "ec_42",
        "ec_43"
      ],
      "instanceType": "StudyDesignPopulation"
    }
  }
}